The role of il-6 in exercise-induced immune changes and metabolism

Exercise Immunology Review

Volumn 9, Issue , 2003, Pages 40-47

  Steensberg, Adam ^a  

^a Rigshospitalet   (Denmark)

Author keywords

Cytokines; Exercise; Lipolysis; Lymphocytes; Metabolism

Indexed keywords

INTERLEUKIN 6;

ANIMAL; EXERCISE; HUMAN; IMMUNOLOGY; METABOLISM; PHYSIOLOGY; REVIEW; SIGNAL TRANSDUCTION; SKELETAL MUSCLE;

ANIMALS; EXERCISE; HUMANS; INTERLEUKIN-6; MUSCLE, SKELETAL; SIGNAL TRANSDUCTION;

EID: 1542678248     PISSN: 10775552     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (48)

1. Alonzi, T., E. Fattori, D. Lazzaro, P. Costa, L. Probert, G. Kollias, F. De Benedetti,V. Poli, and G. Ciliberto. Interleukin 6 is required for the development of collagen-induced arthritis. J Exp.Med. 187: 461-468, 1998. (Pubitemid 28093348)
2. Bagby, G. J., D. E. Sawaya, L. D. Crouch, and R. E. Shepherd. Prior exercise suppresses the plasma tumor necrosis factor response to bacterial lipopolysaccharide. J.Appl.Physiol. 77: 1542-1547, 1994. (Pubitemid 24299415)
3. Bethin, K. E., S. K. Vogt, and L. J. Muglia. Interleukin-6 is an essential, corticotropin-releasing hormone- independent stimulator of the adrenal axis during immune system activation. Proc.Natl.Acad.Sci.U.S.A 97: 9317-9322, 2000. (Pubitemid 30626716)
4. Bruunsgaard, H., H. Galbo, K. J. Halkjaer, T. L. Johansen, D. A. MacLean, and B. K. Pedersen. Exercise-induced increase in serum interleukin-6 in humans is related to muscle damage. J.Physiol.(Lond.) 499: 833-841, 1997. (Pubitemid 27153602)
5. Croisier, J. L., G. Camus, I. Venneman, G. Deby-Dupont, A. Juchmes-Ferir, M. Lamy, J. M. Crielaard, C. Deby, and J. Duchateau. Effects of training on exercise-induced muscle damage and interleukin 6 production. Muscle Nerve 22: 208-212, 1999. (Pubitemid 29070394)
6. Dinarello, C. A. Induction of interleukin-1 and interleukin-1 receptor antagonist. Semin.Oncol. 24: S9, 1997.
7. Dinarello, C. A. Interleukin-1, interleukin-1 receptors and interleukin-1 receptor antagonist. Int.Rev.Immunol. 16: 457-499, 1998. (Pubitemid 28286181)
8. Elenkov, I. J. and G. P. Chrousos. Stress Hormones, Th1/Th2 patterns, Pro/Antiinflammatory Cytokines and Susceptibility to Disease. Trends Endocrinol.Metab 10: 359-368, 1999. (Pubitemid 29496010)
9. Elenkov, I. J. and G. P. Chrousos. Stress hormones, proinflammatory and antiinflammatory cytokines, and autoimmunity. Ann.N.Y.Acad.Sci. 966: 290-303, 2002. (Pubitemid 34729188)
10. Febbraio, M. A. and B. K. Pedersen. Muscle-derived interleukin-6: mechanisms for activation and possible biological roles. FASEB J 16: 1335-1347, 2002. (Pubitemid 34913306)
11. Febbraio, M. A., A. Steensberg, C. Keller, R. L. Starkie, H. B. Nielsen, P. Krustrup, P. Ott, N. H. Secher, and B. K. Pedersen. Glucose ingestion attenuates interleukin-6 release from contracting skeletal muscle in humans. J Physiol 549: 607-612, 2003. (Pubitemid 36701770)
12. Fiers, W. Tumor necrosis factor. Characterization at the molecular, cellular and in vivo level. FEBS Lett. 285: 199-212, 1991.
13. Franchimont, D., J. Galon, M. Gadina, R. Visconti, Y. Zhou, M. Aringer, D. M. Frucht, G. P. Chrousos, and J. J. O'Shea. Inhibition of Th1 immune response by glucocorticoids: dexamethasone selectively inhibits IL-12-induced Stat4 phosphorylation in T lymphocytes. J.Immunol. 164: 1768-1774, 2000. (Pubitemid 30108728)
14. Gadient, R. A. and P. H. Patterson. Leukemia inhibitory factor, Interleukin 6, and other cytokines using the GP130 transducing receptor: roles in inflammation and injury. Stem.Cells 17: 127-137, 1999. (Pubitemid 29226663)
15. Greiwe, J. S., B. Cheng, D. C. Rubin, K. E. Yarasheski, and C. F. Semenkovich. Resistance exercise decreases skeletal muscle tumor necrosis factor alpha in frail elderly humans. FASEB J 15: 475-482, 2001. (Pubitemid 32141439)
16. Ishizashi, H., T. Yoshimoto, K. Nakanishi, J. Tsujita, and S. Hori. Effect of exercise on endotoxin shock with special reference to changes in concentration of cytokines. Jpn.J.Physiol. 45: 553-560, 1995.
17. Kanemaki, T., H. Kitade, M. Kaibori, K. Sakitani, Y. Hiramatsu, Y. Kamiyama, S. Ito, and T. Okumura. Interleukin 1beta and interleukin 6, but not tumor necrosis factor alpha, inhibit insulin-stimulated glycogen synthesis in rat hepatocytes. Hepatology 27: 1296-1303, 1998. (Pubitemid 28227856)
18. Keller, C., A. Steensberg, H. Pilegaard, T. Osada, B. Saltin, B. K. Pedersen, and P. D. Neufer. Transcriptional activation of the IL-6 gene in human contracting skeletal muscle: influence of muscle glycogen content. FASEB J. 15: 2748-2750, 2001.
19. Langberg, H., J. L. Olesen, C. Gemmer, and M. Kjaer. Substantial elevation of interleukin-6 concentration in peritendinous tissue, in contrast to muscle, following prolonged exercise in humans. J Physiol 542: 985-990, 2002. (Pubitemid 34947289)
20. Lucey, D. R., M. Clerici, and G. M. Shearer. Type 1 and type 2 cytokine dysregulation in human infectious, neoplastic, and inflammatory diseases. Clin.Microbiol.Rev. 9: 532-562, 1996. (Pubitemid 26366537)
21. Lyngso, D., L. Simonsen, and J. Bulow. Metabolic effects of interleukin-6 in human splanchnic and adipose tissue. J Physiol 543: 379-386, 2002. (Pubitemid 34947323)
22. Malm, C. Exercise immunology: a skeletal muscle perspective. Exerc.Immunol.Rev. 8: 116-167, 2002.
23. Nehlsen-Cannarella, S. L., O. R. Fagoaga, D. C. Nieman, D. A. Henson, D. E. Butterworth, R. L. Schmitt, E. M. Bailey, B. J. Warren, A. Utter, and J. M. Davis. Carbohydrate and the cytokine response to 2.5 h of running. J.Appl.Physiol. 82: 1662-1667, 1997. (Pubitemid 27203876)
24. Nieman, D. C., J. M. Davis, D. A. Henson, J. Walberg-Rankin, M. Shute, C. L. Dumke, A. C. Utter, D. M. Vinci, J. A. Carson, A. Brown,W. J. Lee, S. R. McAnulty, and L. S. McAnulty. Carbohydrate ingestion influences skeletal muscle cytokine mRNA and plasma cytokine levels after a 3-h run. J Appl.Physiol 94: 1917-1925, 2003. (Pubitemid 36457443)
25. Northoff, H. and A. Berg. Immunologic mediators as parameters of the reaction to strenuous exercise. Int.J.Sports Med. 12 Suppl 1: S9-S15, 1991.
26. Opal, S. M. and V. A. DePalo. Anti-inflammatory cytokines. Chest 117: 1162-1172, 2000. (Pubitemid 30228378)
27. Ostrowski, K., T. Rohde, M. Zacho, S. Asp, and B. K. Pedersen. Evidence that interleukin-6 is produced in human skeletal muscle during prolonged running. J.Physiol 508: 949-953, 1998. (Pubitemid 28220743)
28. Pedersen, B. K. and L. Hoffman-Goetz. Exercise and the immune system: regulation, integration, and adaptation. Physiol Rev. 80: 1055-1081, 2000. (Pubitemid 30452011)
29. Pedersen, B. K., A. Steensberg, and P. Schjerling. Muscle-derived interleukin-6: possible biological effects. J.Physiol 536: 329-337, 2001. (Pubitemid 32976115)
30. Penkowa, M., C. Keller, P. Keller, S. Jauffred, and B. K. Pedersen. Immunohistochemical detection of interleukin-6 in human skeletal muscle fibers following exercise. FASEB J 2003.
31. Pilegaard, H., C. Keller, A. Steensberg, J. W. Helge, B. K. Pedersen, B. Saltin, and Neufer Section. Influence of pre-exercise muscle glycogen content on exercise-induced transcriptional regulation of metabolic genes. J Physiol 541: 261-271, 2002.
32. Rincon, M., J. Anguita, T. Nakamura, E. Fikrig, and R. A. Flavell. Interleukin (IL)-6 directs the differentiation of IL-4-producing CD4+ T cells. J.Exp.Med. 185: 461-469, 1997. (Pubitemid 27078364)
33. Rohde, T., D. A. MacLean, E. A. Richter, B. Kiens, and B. K. Pedersen. Prolonged submaximal eccentric exercise is associated with increased levels of plasma IL-6. Am.J.Physiol. 273: E85-E91, 1997.
34. Starkie, R., S. R. Ostrowski, S. Jauffred, M. Febbraio, and B. K. Pedersen. Exercise and IL-6 infusion inhibit endotoxin-induced TNF-alpha production in humans. FASEB J 17: 884-886, 2003.
35. Starkie, R. L., M. J. Arkinstall, I. Koukoulas, J. A. Hawley, and M. A. Febbraio. Carbohydrate ingestion attenuates the increase in plasma interleukin-6, but not skeletal muscle interleukin-6 mRNA, during exercise in humans. J.Physiol 533: 585-591, 2001. (Pubitemid 32520010)
36. Steensberg, A., M. A. Febbraio, T. Osada, P. Schjerling, G. van Hall, B. Saltin, and B. K. Pedersen. Interleukin-6 production in contracting human skeletal muscle is influenced by pre-exercise muscle glycogen content. J.Physiol 537: 633-639, 2001. (Pubitemid 33130517)
37. Steensberg, A., C. P. Fischer, C. Keller, K. Moller, and B. K. Pedersen. IL-6 enhances plasma IL-1ra, IL-10, and cortisol in humans. Am.J Physiol Endocrinol.Metab 285: E433-E437, 2003. (Pubitemid 36899719)
38. Steensberg, A., C. P. Fischer, M. Sacchetti, C. Keller, T. Osada, P. Schjerling, G. G. Hall, M. A. Febbraio, and B. K. Pedersen. Acute interleukin-6 administration does not impair muscle glucose uptake or whole-body glucose disposal in healthy humans. J Physiol 548: 631-638, 2003. (Pubitemid 36527483)
39. Steensberg, A., C. Keller, R. L. Starkie, T. Osada, M. A. Febbraio, and B. K. Pedersen. IL-6 and TNF-alpha expression in, and release from, contracting human skeletal muscle. Am.J Physiol Endocrinol.Metab 283: E1272-E1278, 2002. (Pubitemid 35340635)
40. Steensberg, A., A. D. Toft, H. Bruunsgaard, M. Sandmand, J. Halkjaer-Kristensen, and B. K. Pedersen. Strenuous exercise decreases the percentage of type 1 T cells in the circulation. J.Appl.Physiol 91: 1708-1712, 2001. (Pubitemid 32900363)
41. Steensberg, A., A. D. Toft, P. Schjerling, J. Halkjaer-Kristensen, and B. K. Pedersen. Plasma interleukin-6 during strenuous exercise: role of epinephrine. Am.J.Physiol Cell Physiol 281: C1001-C1004, 2001.
42. Steensberg, A., G. van Hall, T. Osada, M. Sacchetti, B. Saltin, and P. B. Klarlund. Production of interleukin-6 in contracting human skeletal muscles can account for the exercise-induced increase in plasma interleukin-6. J Physiol 529: 237-242, 2000.
43. Stouthard, J. M., J. A. Romijn, P. T. Van der, E. Endert, S. Klein, P. J. Bakker, C. H. Veenhof, and H. P. Sauerwein. Endocrinologic and metabolic effects of interleukin-6 in humans. Am.J.Physiol 268: E813-E819, 1995.
44. Suzuki, K., S. Nakaji, M. Yamada, M. Totsuka, K. Sato, and K. Sugawara. Systemic inflammatory response to exhaustive exercise. Cytokine kinetics. Exerc.Immunol.Rev. 8: 6-48, 2002.
45. Tsigos, C., D. A. Papanicolaou, I. Kyrou, R. Defensor, C. S. Mitsiadis, and G. P. Chrousos. Dose-dependent effects of recombinant human interleukin-6 on glucose regulation. J.Clin.Endocrinol.Metab 82: 4167-4170, 1997. (Pubitemid 27525533)
46. van Hall, G., A. Steensberg, M. Sacchetti, C. Fischer, C. Keller, P. Schjerling, N. Hiscock, K. Moller, B. Saltin, M. A. Febbraio, and B. K. Pedersen. Interleukin-6 stimulates lipolysis and fat oxidation in humans. J Clin.Endocrinol.Metab 88: 3005-3010, 2003. (Pubitemid 36877463)
47. Wallenius V,Wallenius K, Ahren B, Rudling M, Carlsten H, Dickson SL, Ohlsson C, and Jansson JO. Interleukin-6-deficient mice develop mature-onset obesity. Nature Medicine 8: 75-79, 2002. (Pubitemid 34101732)
48. Xing, Z., J. Gauldie, G. Cox, H. Baumann, M. Jordana, X. F. Lei, and M. K. Achong. IL-6 is an antiinflammatory cytokine required for controlling local or systemic acute inflammatory responses. J.Clin.Invest. 101: 311-320, 1998. (Pubitemid 28067327)